|
 |
| The DVT-IMP project Consortium is developing a prototype device that will detect D-dimer concentration in whole blood, using the latest advances in impedimetric detection, bio-molecular engineering, lab-on-a-chip, wireless ICT and nano-biotechnologies and using conducting polymers for the low-cost and rapid production of printable biosensors.
The device will provide fast, quantitative and reliable measurement of D-dimer concentration, assisting practitioners in performing an early yet effective assessment of patients showing symptoms of deep vein thrombosis or pulmonary embolism.
Aims & Objectives
The aim of the DVT-IMP project is to improve the speed, reliability and accuracy of early assessment of patients displaying symptoms of deep vein thrombosis (DVT) and pulmonary embolism (PE) at the point of first-contact.
The scientific aim of DVT-IMP is the advancement and integration of four key bio-nano-informatics technology areas:
- Bio-engineered D-dimer antibodies for high specificity immunoassay-based diagnostics, using technology owned by Haptogen, a consortium member of DVT-IMP
- Nano/micro engineered impedimetric analysis electrodes incorporating biocompatible conducting polymer substrate
- Development of a disposable microfluidic manifold specifically enabling diagnostics at the point-of-first-contact
- Development of an advanced e-Health medical diagnostic software system.
|
 |
 |
|
|
|
